CBIO smart money
Crescent Biopharma, INC. (CBIO): 2 insider buys, 8 top funds holding it in the public filings.
Insider buys, 12 months$30.6M
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-07-20 | Fairmount Healthcare Fund II L.P. | Director,TenPercentOwner | $12.4M | $14.5 |
| 2025-12-08 | Harwin Peter Evan | Director,TenPercentOwner | $18.2M | $13.41 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 2 | Venrock Adviser, LLC | 1.51% | $31M | |
| 3 | Fairmount Funds Management LLC | ADD +31% | 3.30% | $52M |
| 9 | Bvf INC/Il | ADD +13% | 1.48% | $45M |
| 15 | Logos Global Management LP | TRIM -55% | 0.75% | $12M |
| 50 | Siren, L.L.C. | BUY | 0.14% | $6M |
| 63 | Vestal Point Capital, LP | ADD +84% | 1.13% | $44M |
| 72 | Sphera Funds Management LTD. | BUY | 0.62% | $4M |
| 86 | Adar1 Capital Management, LLC | ADD +1166% | 0.16% | $3M |